Design: A crossover repeated measures design with random assignment was used.
This was a block counterbalanced, crossover, repeated measures study design utilizing 20 individuals without self-reported shoulder or cervical pathology.
Here we test report pilot testing of such a device, ArmSense (patented), using a crossover repeated-measures design.
A crossover repeated measures design was employed, with two independent variables: lower body stabilization (with/without) and pencil (regular/assigned grip height/biaxial).
This study examined BTM responses to acute high-intensity RE and high-intensity RE with WBV (WBV + RE) in young women (n = 10) taking oral contraceptives in a randomized, crossover repeated measures design.
We adopted randomized, double-blind, crossover repeated measures designs for both studies.
Design: A repeated-measure design.
A randomized, crossover, within-participant, repeated-measures, nonblind design was adopted.
Nine subjects received either the experimental or placebo cake in a counterbalanced fashion using a crossover, double-blind, repeated-measures design.
Consequently, during the crossover period the repeated measure would contain utility observations that occurred in the initial diagnosis of progressed disease, but then also the active treatment with regorafenib.
